Dallas, TX, United States of America

Carolyn Michnoff


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Carolyn Michnoff

Introduction

Carolyn Michnoff is a notable inventor based in Dallas, TX, who has made significant contributions to the field of biochemistry. With a total of two patents to her name, she has focused her research on novel kinases, particularly the PAS kinase.

Latest Patents

Her latest patents revolve around the invention of methods and compositions related to a novel kinase designated as PAS Kinase (PASK). The compositions include isolated polypeptides that comprise a native PASK protein or a PASK N-terminal domain. Additionally, her patents cover polypeptides consisting of a PASK PAS-A or PAS-B domain, as well as isolated polynucleotides encoding such polypeptides. The methods outlined in her patents include binding assays that involve incubating a mixture containing a subject polypeptide with a ligand under conditions that facilitate binding, followed by detecting the interaction between the polypeptide and the ligand.

Career Highlights

Carolyn Michnoff is affiliated with the University of Texas System, where she continues to advance her research and innovation in the field. Her work has garnered attention for its potential applications in various biotechnological and pharmaceutical contexts.

Collaborations

Some of her notable coworkers include Steven L McKnight and Kevin H Gardner, who have collaborated with her on various research projects.

Conclusion

Carolyn Michnoff's contributions to the field of biochemistry through her innovative patents highlight her role as a leading inventor in her area of expertise. Her work on PAS kinase demonstrates the importance of research in developing new methodologies and compositions that can have a significant impact on science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…